A Comparative Study of a Potent CNS-Permeable RARβ-Modulator, Ellorarxine, in Neurons, Glia and Microglia Cells In Vitro
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083551 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yunxi Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, Durham University, Durham DH1 3LE, UK. Hauptthemen laut MEDLINE: Receptors, Retinoic Acid, Neurons, Microglia, Neuroglia. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council Studentship from Durham University.
Abstract (Originalsprache)
Vitamin A (retinol) and its derivatives (retinoids) assume critical roles in neural development, cellular differentiation, axon elongation, programmed cell apoptosis and various fundamental cellular processes. Retinoids function by binding to specific nuclear receptors, such as retinoic acid receptors (RARs) and retinoid X receptors (RXRs), activating specific signalling pathways in the cells. The disruption of the retinoic acid signalling pathway can result in neuroinflammation, oxidative and ER stress and mitochondrial dysfunction and has been implicated in a wide range of neurodegenerative diseases. The present study explored the potential therapeutic application of our innovative CNS-permeable synthetic retinoid, Ellorarxine, for the treatment of neurodegenerative disorders in vitro. An MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium assay, lactate dehydrogenase (LDH) assay, enzyme-linked immunosorbent assay (ELISA), immunocytochemistry and immunofluorescence staining were performed. Ellorarxine increased Cyp26 and, selectively, RARβ protein expression in neurons, glia and microglia. Ellorarxine significantly reduced cell death (neurons, glia), increased mitochondrial viability (neurons), modulated cytokine release (microglia), and positively regulated cellular autophagy (neurons, glia, microglia). These results suggest that Ellorarxine is a promising drug candidate that should be further investigated in the treatment of neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences, Durham University, Durham DH1 3LE, UK.
- Department of Pharmacology, University College London, London WC1E 6BT, UK.
- Department of Chemistry, Science Laboratories, Durham University, South Road, Durham DH1 3LE, UK.
ORCID-Profile: Lilie Gailloud, Andrew Whiting, Paul Chazot
Förderung
- China Scholarship Council Studentship from Durham University
Zitieren
APA
Zhang, Y., Gailloud, L., Shin, A., Fewkes, J., Pinckney, R., Whiting, A., & Chazot, P. (2025). A Comparative Study of a Potent CNS-Permeable RARβ-Modulator, Ellorarxine, in Neurons, Glia and Microglia Cells In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083551
Vancouver
Zhang Y, Gailloud L, Shin A, Fewkes J, Pinckney R, Whiting A, et al. A Comparative Study of a Potent CNS-Permeable RARβ-Modulator, Ellorarxine, in Neurons, Glia and Microglia Cells In Vitro. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083551
BibTeX
@article{Zhang2025,
author = {Zhang, Yunxi and Gailloud, Lilie and Shin, Alexander and Fewkes, Jessica and Pinckney, Rosella and Whiting, Andrew and Chazot, Paul},
title = {A Comparative Study of a Potent CNS-Permeable RARβ-Modulator, Ellorarxine, in Neurons, Glia and Microglia Cells In Vitro},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083551}
}
EUVIMED